08/31/03 - Graftys® BCP, synthetic bone void filler, has been FDA approved for its indications in orthopaedics.The Graftys® BCP has had EC accreditation since January 2007.
About Graftys
Graftys is a Young Innovative Company specializing in bone tissue engineering. Graftys has strong expertise in biomaterials synthesis and works in several original directions with a view to have eventually one of the widest product offers on the market... Graftys' Press Release - Communiqué de Presse de Graftys -
